Yngvi Bio
PrivateLast Round
Convertible Debt
Sep 8, 2026
Total Funding Raised
$2.79M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Yngvi Bio operates in Healthcare & Life Sciences and is based in Copenhagen. Its latest recorded funding round was a Convertible Debt round in September 2026.
Yngvi Bio is a biotechnology company developing protein-based, biodegradable crop protection solutions to replace chemical pesticides.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Yngvi Bio Comparables
Compare Yngvi Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Solasta Bio | 85% | |
| Molagri | 81% | |
| Invaio Sciences | 78% |
For institutional investors. Book with your work email.
Yngvi Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Sep 8, 2026 | ||||
| Grant | Jul 29, 2025 | ||||
| Grant | Jun 26, 2025 | ||||
| Accelerator | Jan 14, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Yngvi Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Novo Nordisk Foundation | Grant |
| Heyfunding | Grant |
| Antler | Grant |
| BioInnovation Institute | Convertible Debt, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 8, 2026
$1.51M raised, led by BioInnovation Institute.
- Oct 14, 2025
Grew 60% QoQ from 5 to 8 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingSep 8, 2026
As of Sep 8th '26, Yngvi Bio has previously secured $581K in financing from Copenhagen-based BioInnovation Institute.
- is_developingSep 8, 2026
Yngvi Bio, a University of Copenhagen spin-out, is developing biological pest-control solutions to protect crops while limiting harm to biodiversity and human health.
For institutional investors. Book with your work email.
Yngvi Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Yngvi Bio's valuation, stock price, and market status.
Is Yngvi Bio a public or private company?
Yngvi Bio is a private company.
What is the current stock price of Yngvi Bio?
Yngvi Bio is a private company, so its shares have no public market price. Caplight tracks Yngvi Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Yngvi Bio worth (valuation)?
Valuation information for Yngvi Bio is not publicly available.
Can I buy Yngvi Bio stock?
Yngvi Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Yngvi Bio's last funding round?
Yngvi Bio's most recent funding round was Convertible Debt on September 8, 2026.
Who are the main investors in Yngvi Bio?
Key investors in Yngvi Bio include BioInnovation Institute.
Will Yngvi Bio IPO soon?
No public IPO plans have been announced for Yngvi Bio.
How can I track Yngvi Bio secondary market activity?
Caplight tracks bids, offers, and trades in Yngvi Bio's shares on secondary markets.